Related Experiment Videos
Protein markers in cerebrospinal fluid from BSE-affected cattle
1Central Veterinary Laboratory, Surrey.
The Veterinary Record
|October 12, 1996
Summary
Cerebrospinal fluid (CSF) analysis revealed distinct protein changes in confirmed bovine spongiform encephalopathy (BSE) cases. These biomarkers, including apolipoprotein E and two unidentified proteins, could aid in early BSE detection.
Area of Science:
- Veterinary Neurology
- Biochemistry
- Neuroscience
Background:
- Bovine spongiform encephalopathy (BSE) is a fatal neurodegenerative disease in cattle.
- Accurate and early diagnosis of BSE is crucial for animal health and public safety.
- Current diagnostic methods for BSE often rely on post-mortem examination.
Purpose of the Study:
- To identify potential protein biomarkers in cerebrospinal fluid (CSF) for the diagnosis of bovine spongiform encephalopathy (BSE).
- To evaluate the utility of these biomarkers in distinguishing between confirmed BSE cases and other conditions.
Main Methods:
- Two-dimensional gel electrophoresis was employed to analyze CSF proteomes.
- CSF samples were collected from cattle with suspected and confirmed BSE, normal cattle, and experimentally infected cattle at various stages.
- Protein profiles were compared between groups to identify differential expression patterns.
Main Results:
- Consistent changes in CSF protein profiles were observed in confirmed BSE cases and early-stage experimental infections.
- Increased staining intensity of apolipoprotein E was noted.
- Two unidentified protein spots (35 and 36 kDa, pI 5.5) were present in BSE-positive samples.
- These changes were absent in normal cattle and pre-clinical experimental infections.
Conclusions:
- Specific protein alterations in CSF, including apolipoprotein E and two novel proteins, show promise as diagnostic markers for bovine spongiform encephalopathy (BSE).
- These CSF biomarkers could facilitate earlier detection of BSE compared to traditional methods.
- Further research is warranted to fully identify the novel proteins and validate their diagnostic accuracy.